| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.0M | -4.1% |
| Cost of Revenue | $5.2M | +12.5% |
| Gross Profit | $4.7M | -17.6% |
| R&D Expense | $1.3M | -42.1% |
| SG&A Expense | $7.6M | -1.5% |
| Operating Income | -$4.3M | +0.0% |
| Interest Expense | $20K | -51.2% |
| Income Tax | $0 | — |
| Net Income | -$7.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.6M | -47.9% |
| Accounts Receivable | $1.3M | -21.6% |
| Inventory | $3.2M | -34.2% |
| Current Assets | $8.3M | -39.4% |
| Total Assets | $11.0M | -37.7% |
| Current Liabilities | $1.4M | -40.9% |
| Long-term Debt | $71K | -79.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.2M | -128.2% |
| Capital Expenditures | $137K | +280.6% |
| Investing Cash Flow | -$137K | -61.2% |
| Financing Cash Flow | $34K | -85.7% |
| Free Cash Flow | -$3.4M | -132.0% |
| -83.8% |
| EPS (Basic) | -$0.73 | -78.0% |
| Total Liabilities |
| $2.1M |
| -27.0% |
| Stockholders' Equity | $5.6M | -52.2% |